ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 20,300 | $193,459 | 0.00% |
| Citadel Advisors | 54,408 | $518,509 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 115,300 | $1,098,809 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 35,900 | $342,127 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,881 | $141,816 | 0.00% |
| SIGNATUREFD, LLC | 368 | $3,507 | 0.00% |
| Daiwa Securities Group Inc. | 245 | $2 | 0.00% |
| Qube Research & Technologies Ltd | 13,631 | $129,903 | 0.00% |
| Lindbrook Capital, LLC | 84 | $801 | 0.00% |
External links
This page lists ARCUTIS BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view ARCUTIS BIOTHERAPEUTICS INC's shareholder history, click here.